Assignee
HADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED
IL·4 granted patents·8 pending applications·1 citations·filing 2013–2025
Top patents by PatentIndex Score
12 records- 0159US10188706B2Plasminogen activator mutants as anti-fibrinolytic agentsHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2013·Granted Jan 29, 2019·1 cites·14 claims
- 0258US2023414791A1Non-metallic magnetic resonance contrast agentHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2023·Application pending·0 cites
- 0349US10174285B2Methods of obtaining cell populations enriched with desired cellsHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2015·Granted Jan 8, 2019·0 cites·9 claims
- 0445US11771779B2Non-metallic magnetic resonance contrast agentHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2019·Granted Oct 3, 2023·0 cites·11 claims
- 0544US2019134096A1Hyperimmune colostrum in the modulation and treatment of conditions associated with the mammalian microbiomeHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2017·Application pending·0 cites
- 0642US2018080007A1Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous systemHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2017·Application pending·0 cites
- 0740US10336985B2Method of obtaining terminally differentiated neuronal lineages and uses thereofHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2014·Granted Jul 2, 2019·0 cites·13 claims
- 0838US2023295597A1A disintegrin and metalloproteinase with a thrombospondin type i motif, member 13 (adamts-13) mutants, compositions and therapeutic methods thereofHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2021·Application pending·0 cites
- 0938US2025387378A1Methods and compositions for preventing skin toxicities caused by biological targeted cancer drugsHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2025·Application pending·0 cites
- 1037US2019264172A1Method of obtaining terminally differentiated neuronal lineages and uses thereofHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2019·Application pending·0 cites
- 1134US2019254992A1Combinations of beta-glycolipides and 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol, compositions and uses thereof in the treatment of disorders associated with protein misfolding and protein aggregationsHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2017·Application pending·0 cites
- 1233US2022296543A1Methods and compositions for preventing skin toxicities caused by biological targeted cancer drugsHADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HADASIT MEDICAL RES SERVICES & DEVELOPMENT LIMITED files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →